Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Endocrinological Investigation
Published in: Journal of Endocrinological Investigation 9/2006

01-10-2006 | Original Articles

GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome

Authors: R. Salvatori, MD, M. G. Serpa, G. Parmigiani, A. V. O. Britto, J. L. M. Oliveira, C. R. P. Oliveira, C. M. Prado, C. T. Farias, J. C. Almeida, T. A. R. Vicente, M. H. Aguiar-Oliveira

Published in: Journal of Endocrinological Investigation | Issue 9/2006

Login to get access
Metadata
Title
GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome
Authors
R. Salvatori, MD
M. G. Serpa
G. Parmigiani
A. V. O. Britto
J. L. M. Oliveira
C. R. P. Oliveira
C. M. Prado
C. T. Farias
J. C. Almeida
T. A. R. Vicente
M. H. Aguiar-Oliveira
Publication date
01-10-2006
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 9/2006
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/BF03347374

Other articles of this Issue 9/2006

Journal of Endocrinological Investigation 9/2006 Go to the issue

Original Articles

Long-term effects of elevated gastrin levels on calcitonin secretion

Announcement

4th International Meeting on Steroids and Nervous System

Case Report

Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: Preferential expression of somatostatin receptor subtype 3

Rapid Communication

A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules

Case Report

Development of acromegaly in a patient with anorexia nervosa: Pathogenetic and diagnostic implications

Original Articles

Ghrelin and cortistatin in lung cancer: Expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits